Literature DB >> 22657952

Neurocognitive function in long-term treated schizophrenia: a five-year follow-up study.

Maria Ekerholm1, Svala Firus Waltersson, Thomas Fagerberg, Erik Söderman, Lars Terenius, Ingrid Agartz, Erik Gunnar Jönsson, Håkan Nyman.   

Abstract

Neurocognitive deficits are a core feature of schizophrenia. Deficits covering a wide range of functions have been well documented. However there is still a lack of longitudinal studies regarding the development of neurocognitive impairment. The current study examined the effect of time in long-term treated patients with schizophrenia and healthy controls on cognitive functions. A neurocognitive test-battery was administered to 36 patients and 46 controls on two occasions with approximately 4.5 years interval. Patients performed significantly worse on all measures on both occasions. The only significant decline over time was the ability to shift mental set between different rules or categories (measured by Trail Making Test B). This decline was present in both patients and controls. Improvement on attention (tested by Continuous Performance Test) was found in patients only and improvement on verbal learning (tested by Rey Auditory Verbal Learning Test) was found only in controls. Education was significantly related to outcome in patients and age was related to outcome in controls. We conclude that neurocognitive function is relatively stable over 4.5 years in patients with long-term treated schizophrenia, in line with previous scientific research. The authors discuss the impact of age and education and limitations of the study.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22657952     DOI: 10.1016/j.psychres.2012.05.008

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  6 in total

Review 1.  The role of long-acting injectable antipsychotics in schizophrenia: a critical appraisal.

Authors:  Sofia Brissos; Miguel Ruiz Veguilla; David Taylor; Vicent Balanzá-Martinez
Journal:  Ther Adv Psychopharmacol       Date:  2014-10

2.  The Relationship Between Polygenic Risk Scores and Cognition in Schizophrenia.

Authors:  Alexander L Richards; Antonio F Pardiñas; Aura Frizzati; Katherine E Tansey; Amy J Lynham; Peter Holmans; Sophie E Legge; Jeanne E Savage; Ingrid Agartz; Ole A Andreassen; Gabriella A M Blokland; Aiden Corvin; Donna Cosgrove; Franziska Degenhardt; Srdjan Djurovic; Thomas Espeseth; Laura Ferraro; Charlotte Gayer-Anderson; Ina Giegling; Neeltje E van Haren; Annette M Hartmann; John J Hubert; Erik G Jönsson; Bettina Konte; Leonhard Lennertz; Loes M Olde Loohuis; Ingrid Melle; Craig Morgan; Derek W Morris; Robin M Murray; Håkan Nyman; Roel A Ophoff; Jim van Os; Tracey L Petryshen; Diego Quattrone; Marcella Rietschel; Dan Rujescu; Bart P F Rutten; Fabian Streit; Jana Strohmaier; Patrick F Sullivan; Kjetil Sundet; Michael Wagner; Valentina Escott-Price; Michael J Owen; Gary Donohoe; Michael C O'Donovan; James T R Walters
Journal:  Schizophr Bull       Date:  2020-02-26       Impact factor: 9.306

3.  Neurocognitive Impairments in Deficit and Non-Deficit Schizophrenia and Their Relationships with Symptom Dimensions and Other Clinical Variables.

Authors:  Miao Yu; XiaoWei Tang; Xiang Wang; XiangRong Zhang; XiaoBin Zhang; WeiWei Sha; ShuQiao Yao; Ni Shu; XiangYang Zhang; ZhiJun Zhang
Journal:  PLoS One       Date:  2015-09-18       Impact factor: 3.240

4.  Interleukin-6: the missing element of the neurocognitive deterioration in schizophrenia? The focus on genetic underpinnings, cognitive impairment and clinical manifestation.

Authors:  Dorota Frydecka; Błażej Misiak; Edyta Pawlak-Adamska; Lidia Karabon; Anna Tomkiewicz; Paweł Sedlaczek; Andrzej Kiejna; Jan Aleksander Beszłej
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-09-12       Impact factor: 5.270

5.  Poor premorbid school performance, but not severity of illness, predicts cognitive decline in schizophrenia in midlife.

Authors:  Irina Rannikko; Graham K Murray; Pauliina Juola; Henri Salo; Marianne Haapea; Jouko Miettunen; Juha Veijola; Jennifer H Barnett; Anja P Husa; Peter B Jones; Marjo-Riitta Järvelin; Matti Isohanni; Erika Jääskeläinen
Journal:  Schizophr Res Cogn       Date:  2015-09-09

6.  Age at Onset and Social Cognitive Impairment in Clinically Stabilized Patients with Schizophrenia: An Ecological Cross-Sectional Study.

Authors:  Alice Caldiroli; Marta Serati; Giulia Orsenigo; Elisabetta Caletti; Massimiliano Buoli
Journal:  Iran J Psychiatry       Date:  2018-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.